Research News
View articles by month and year
1–4 of 4 articles
-
Dose-Dense Ellence Regimen Better for High-Risk Breast Cancer Than Early-Stage Breast Cancer
Two studies looking at a dose-dense regimen of Ellence compared to a standard schedule found that the dose-dense regimen is better for high-risk breast cancer.
-
Taxol Weekly Better Than Every Three Weeks for Breast Cancer
Getting Taxol (chemical name: placlitaxel) every week seems to have more benefits than getting it every 3 weeks or getting Taxotere (chemical name: docetaxel) on either schedule.
-
Herceptin with Dose-Dense Chemo Reduces Risk of Heart Problems
A small study has found that when Herceptin (chemical name: trastuzumab) was given in combination with dose-dense chemotherapy, the risk of heart problems from Herceptin was lower than when Herceptin was given with a routine schedule of chemotherapy.
-
Chemo Raises Leukemia Risk Slightly in Older Women
Women who receive chemotherapy have a small increase in risk for a type of leukemia later in life.
1–4 of 4 articles
